YY1-inudced activation of lncRNA DUXAP8 promotes proliferation and suppresses apoptosis of triple negative breast cancer cells through upregulating SAPCD2

References

• Mouh FZ, Mzibri ME, Slaoui M, Amrani M. Recent progress in triple negative breast cancer research. Asian Pac J Cancer Prev: APJCP. 2016;17:1595–1608. doi:10.7314/APJCP.2016.17.4.1595.
   PubMedGoogle Scholar
• Mayer IA, Abramson VG, Lehmann BD, Pietenpol JA. New strategies for triple-negative breast cancer–deciphering the heterogeneity. Clin Cancer Res. 2014;20:782–790. doi:10.1158/1078-0432.CCR-13-0583.
   PubMed Web of Science ®Google Scholar
• Sharma P. Biology and management of patients with triple-negative breast cancer. oncologist. 2016;21:1050–1062. doi:10.1634/theoncologist.2016-0067.
   PubMed Web of Science ®Google Scholar
• Li X, Wu Z, Fu X, Han W. lncRNAs: insights into their function and mechanics in underlying disorders. Mutat Res Rev Mutat Res. 2014;762:1–21. doi:10.1016/j.mrrev.2014.04.002.
   PubMed Web of Science ®Google Scholar
• Duguang L, Jin H, Xiaowei Q, Peng X, Xiaodong W, Zhennan L, Jianjun Q, Jie Y. The involvement of lncRNAs in the development and progression of pancreatic cancer. Cancer Biol Ther. 2017;18:927–936. doi:10.1080/15384047.2017.1385682.
   PubMed Web of Science ®Google Scholar
• Huo X, Han S, Wu G, Latchoumanin O, Zhou G, Hebbard L, George J, Qiao L. Dysregulated long noncoding RNAs (lncRNAs) in hepatocellular carcinoma: implications for tumorigenesis, disease progression, and liver cancer stem cells. Mol Cancer. 2017;16:165. doi:10.1186/s12943-017-0734-4.
   PubMed Web of Science ®Google Scholar
• Grelet S, Link LA, Howley B, Obellianne C, Palanisamy V, Gangaraju VK, Diehl JA, Howe PH. A regulated PNUTS mRNA to lncRNA splice switch mediates EMT and tumour progression. Nat Cell Biol. 2017;19:1105–1115. doi:10.1038/ncb3595.
   PubMed Web of Science ®Google Scholar
• Tang XJ, Wang W, Hann SS. Interactions among lncRNAs, miRNAs and mRNA in colorectal cancer. Biochimie. 2019;163:58–72. doi:10.1016/j.biochi.2019.05.010.
   PubMed Web of Science ®Google Scholar
• Kondo Y, Shinjo K, Katsushima K. Long non-coding RNAs as an epigenetic regulator in human cancers. Cancer Sci. 2017;108:1927–1933. doi:10.1111/cas.13342.
   PubMed Web of Science ®Google Scholar
• Bhan A, Soleimani M, Mandal SS. Long noncoding RNA and cancer: a new paradigm. Cancer Res. 2017;77:3965–3981. doi:10.1158/0008-5472.CAN-16-2634.
   PubMed Web of Science ®Google Scholar
• Ballantyne MD, McDonald RA, Baker AH. lncRNA/MicroRNA interactions in the vasculature. Clin Pharmacol Ther. 2016;99:494–501. doi:10.1002/cpt.355.
   PubMed Web of Science ®Google Scholar
• Li L, Wang M, Mei Z, Cao W, Yang Y, Wang Y, Wen A. lncRNAs HIF1A-AS2 facilitates the up-regulation of HIF-1alpha by sponging to miR-153-3p, whereby promoting angiogenesis in HUVECs in hypoxia. Biomed Pharmacother = Biomedecine & Pharmacotherapie. 2017;96:165–172. doi:10.1016/j.biopha.2017.09.113.
   PubMed Web of Science ®Google Scholar
• Zhao X, Hao S, Wang M, Xing D, Wang C. Knockdown of pseudogene DUXAP8 expression in glioma suppresses tumor cell proliferation. Oncol Lett. 2019;17:3511–3516. doi:10.3892/ol.2019.9994.
   PubMed Web of Science ®Google Scholar
• Lian Y, Yang J, Lian Y, Xiao C, Hu X, Xu H. DUXAP8, a pseudogene derived lncRNA, promotes growth of pancreatic carcinoma cells by epigenetically silencing CDKN1A and KLF2. Cancer Commun (London, England). 2018;38:64. doi:10.1186/s40880-018-0333-9.
   PubMed Web of Science ®Google Scholar
• Lin MG, Hong YK, Zhang Y, Lin BB, He XJ. Mechanism of lncRNA DUXAP8 in promoting proliferation of bladder cancer cells by regulating PTEN. Eur Rev Med Pharmacol Sci. 2018;22:3370–3377. doi:10.26355/eurrev_201806_15158.
   PubMed Web of Science ®Google Scholar
• Jiang B, Hailong S, Yuan J, Zhao H, Xia W, Zha Z, Bin W, Liu Z. Identification of oncogenic long noncoding RNA SNHG12 and DUXAP8 in human bladder cancer through a comprehensive profiling analysis. Biomed Pharmacother = Biomedecine & Pharmacotherapie. 2018;108:500–507. doi:10.1016/j.biopha.2018.09.025.
   PubMed Web of Science ®Google Scholar
• Lopez-Pajares V, Qu K, Zhang J, Webster DE, Barajas BC, Siprashvili Z, Zarnegar BJ, Boxer LD, Rios EJ, Tao S, et al. A LncRNA-MAF:MAFB transcription factor network regulates epidermal differentiation. Dev Cell. 2015;32:693–706. doi:10.1016/j.devcel.2015.01.028.
   PubMed Web of Science ®Google Scholar
• Ng SY, Bogu GK, Soh BS, Stanton LW. The long noncoding RNA RMST interacts with SOX2 to regulate neurogenesis. Mol Cell. 2013;51:349–359. doi:10.1016/j.molcel.2013.07.017.
   PubMed Web of Science ®Google Scholar
• Wang H, Huo X, Yang XR, He J, Cheng L, Wang N, Deng X, Jin H, Wang N, Wang C, et al. STAT3-mediated upregulation of lncRNA HOXD-AS1 as a ceRNA facilitates liver cancer metastasis by regulating SOX4. Mol Cancer. 2017;16:136. doi:10.1186/s12943-017-0680-1.
   PubMed Web of Science ®Google Scholar
• Guo LL, Song CH, Wang P, Dai LP, Zhang JY, Wang KJ. Competing endogenous RNA networks and gastric cancer. World J Gastroenterol. 2015;21:11680–11687. doi:10.3748/wjg.v21.i41.11680.
   PubMed Web of Science ®Google Scholar
• Marin-Bejar O, Mas AM, Gonzalez J, Martinez D, Athie A, Morales X, Galduroz M, Raimondi I, Grossi E, Guo S, et al. The human lncRNA LINC-PINT inhibits tumor cell invasion through a highly conserved sequence element. Genome Biol. 2017;18:202. doi:10.1186/s13059-017-1331-y.
   PubMed Web of Science ®Google Scholar
• Zhang A, Xu M, Mo YY. Role of the lncRNA-p53 regulatory network in cancer. J Mol Cell Biol. 2014;6:181–191. doi:10.1093/jmcb/mju013.
   PubMed Web of Science ®Google Scholar
• Lin A, Li C, Xing Z, Hu Q, Liang K, Han L, Wang C, Hawke DH, Wang S, Zhang Y, et al. The LINK-A lncRNA activates normoxic HIF1alpha signalling in triple-negative breast cancer. Nat Cell Biol. 2016;18:213–224. doi:10.1038/ncb3295.
   PubMed Web of Science ®Google Scholar
• Eades G, Wolfson B, Zhang Y, Li Q, Yao Y, Zhou Q. lincRNA-RoR and miR-145 regulate invasion in triple-negative breast cancer via targeting ARF6. Mol Cancer Res: MCR. 2015;13:330–338. doi:10.1158/1541-7786.MCR-14-0251.
   PubMed Web of Science ®Google Scholar
• Du C, Wang HX, Chen P, Chen CH. STAT3-induced upregulation of lncRNA DUXAP8 functions as ceRNA for miR-577 to promote the migration and invasion in colorectal cancer through the regulation of RAB14. Eur Rev Med Pharmacol Sci. 2019;23:6105–6118. doi:10.26355/eurrev_201907_18424.
   PubMed Web of Science ®Google Scholar
• Qiao K, Ning S, Wan L, Wu H, Wang Q, Zhang X, Xu S, Pang D. LINC00673 is activated by YY1 and promotes the proliferation of breast cancer cells via the miR-515-5p/MARK4/Hippo signaling pathway. J Exp Clin Cancer Res: CR. 2019;38:418. doi:10.1186/s13046-019-1421-7.
   PubMed Web of Science ®Google Scholar
• Yan Z, Yang Q, Xue M, Wang S, Hong W. YY1-induced lncRNA ZFPM2-AS1 facilitates cell proliferation and invasion in small cell lung cancer via upregulating of TRAF4. Cancer Cell Int. 2020;20:108.
   PubMed Web of Science ®Google Scholar
• Zhou H, Li J, Zhang Z, Ye R, Shao N, Cheang T, Wang S. RING1 and YY1 binding protein suppresses breast cancer growth and metastasis. Int J Oncol. 2016;49:2442–2452. doi:10.3892/ijo.2016.3718.
   PubMed Web of Science ®Google Scholar
• He H, Wang N, Yi X, Tang C, Wang D. Long non-coding RNA H19 regulates E2F1 expression by competitively sponging endogenous miR-29a-3p in clear cell renal cell carcinoma. Cell Biosci. 2017;7:65. doi:10.1186/s13578-017-0193-z.
   PubMed Web of Science ®Google Scholar
• Wang X, Liu S, Cao L, Zhang T, Yue D, Wang L, Ping Y, He Q, Zhang C, Wang M, et al. miR-29a-3p suppresses cell proliferation and migration by downregulating IGF1R in hepatocellular carcinoma. Oncotarget. 2017;8:86592–86603. doi:10.18632/oncotarget.21246.
   PubMedGoogle Scholar
• Ma Y, Sun Y. miR-29a-3p inhibits growth, proliferation, and invasion of papillary thyroid carcinoma by suppressing NF-κB signaling via direct targeting of OTUB2. Cancer Manag Res. 2019;11:13–23. doi:10.2147/CMAR.S184781.
   PubMed Web of Science ®Google Scholar
• Bai F, Jiu M, You Y, Feng Y, Xin R, Liu X, Mo L, Nie Y. miR‑29a‑3p represses proliferation and metastasis of gastric cancer cells via attenuating HAS3 levels. Mol Med Rep. 2018;17:8145–8152. doi:10.3892/mmr.2018.8896.
   PubMed Web of Science ®Google Scholar
• Luo Y, Wang L, Ran W, Li G, Xiao Y, Wang X, Zhao H, Xing X. Overexpression of SAPCD2 correlates with proliferation and invasion of colorectal carcinoma cells. Cancer Cell Int. 2020;20:43.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Liu JL, Wang J. SAPCD2 promotes invasiveness and migration ability of breast cancer cells via YAP/TAZ. Eur Rev Med Pharmacol Sci. 2020;24:3786–3794. doi:10.26355/eurrev_202004_20844.
   PubMedGoogle Scholar
• Jia X, Niu P, Xie C, Liu H. Long noncoding RNA PXN-AS1-L promotes the malignancy of nasopharyngeal carcinoma cells via upregulation of SAPCD2. Cancer Medicine. 2019;8:4278–4291. doi:10.1002/cam4.2227.
   PubMed Web of Science ®Google Scholar
• Wang X, Lai Q, He J, Li Q, Ding J, Lan Z, Gu C, Yan Q, Fang Y, Zhao X, et al. LncRNA SNHG6 promotes proliferation, invasion and migration in colorectal cancer cells by activating TGF-β/Smad signaling pathway via targeting UPF1 and inducing EMT via regulation of ZEB1. Int J Med Sci. 2019;16:51–59. doi:10.7150/ijms.27359.
   PubMed Web of Science ®Google Scholar
• Su W, Feng S, Chen X, Yang X, Mao R, Guo C, Wang Z, Thomas DG, Lin J, Reddy RM, et al. Silencing of long noncoding RNA MIR22HG triggers cell survival/death signaling via oncogenes YBX1, MET, and p21 in lung cancer. Cancer Res. 2018;78:3207–3219. doi:10.1158/0008-5472.CAN-18-0222.
   PubMed Web of Science ®Google Scholar
• Li Z, Hong S, Liu Z. LncRNA LINC00641 predicts prognosis and inhibits bladder cancer progression through miR-197-3p/KLF10/PTEN/PI3K/AKT cascade. Biochem Biophys Res Commun. 2018;503:1825–1829. doi:10.1016/j.bbrc.2018.07.120.
   PubMed Web of Science ®Google Scholar
• Luan X, Wang Y. LncRNA XLOC_006390 facilitates cervical cancer tumorigenesis and metastasis as a ceRNA against miR-331-3p and miR-338-3p. J Gynecol Oncol. 2018;29:e95.
   PubMed Web of Science ®Google Scholar
• Zhang E, Han L, Yin D, He X, Hong L, Si X, Qiu M, Xu T, De W, Xu L, et al. H3K27 acetylation activated-long non-coding RNA CCAT1 affects cell proliferation and migration by regulating SPRY4 and HOXB13 expression in esophageal squamous cell carcinoma. Nucleic Acids Res. 2017;45:3086–3101. doi:10.1093/nar/gkw1247.
   PubMed Web of Science ®Google Scholar
• Tang R, Chen J, Tang M, Liao Z, Zhou L, Jiang J, Hu Y, Liao Q, Xiong W, Tang Y, et al. LncRNA SLCO4A1-AS1 predicts poor prognosis and promotes proliferation and metastasis via the EGFR/MAPK pathway in colorectal cancer. Int J Biol Sci. 2019;15:2885–2896. doi:10.7150/ijbs.38041.
   PubMed Web of Science ®Google Scholar